Insmed

Insmed

Yahoo Finance • 12 days ago

Goldman rebalances its long duration stock basket

[Interest rate percentage sign symbol finance investment graph chart] alexsl The Goldman Sachs equity team has rebalanced its Long Duration Basket amid rising interest rates. Equities usually struggle to digest sharp increases in interes... Full story

Yahoo Finance • 15 days ago

Exiting Insmed (INSM) Following Disappointing Key Drug Uptake

American Century Investments, an investment management company, released its second-quarter 2026 investor letter for the "American Century Investments Focused Dynamic Growth Fund". The letter can be downloaded here. U.S. stocks advanced sh... Full story

Yahoo Finance • 23 days ago

Do You Believe in Insmed’s INSM) Long-Term Potential Despite Short-Term Challenges?

Artisan Partners, an investment management company, released its second-quarter 2026 investor commentary for the "Artisan Global Opportunities Strategy". The letter can be downloaded here. Global equities rebounded sharply during the quart... Full story

Yahoo Finance • 30 days ago

Billionaire Stanley Druckenmiller Is Quietly Loading Up on Healthcare Stocks -- Here's What His New Positions Reveal

Billionaire Stanley Druckenmiller, who runs the Duquesne Family Office hedge fund, has been loading up on healthcare stocks. A year ago, healthcare stocks represented almost 22% of the fund's portfolio. Today, that representation is up to... Full story

Yahoo Finance • last month

Stanley Druckenmiller builds $120 million bet on major tech stock

Tech investors are back in record territory, but the relentless rally carries an expensive question. The Nasdaq is up 15% in 2026, even as the AI arms race continues to accelerate, according to Reuters. Consensus estimates put combined C... Full story

Yahoo Finance • 2 months ago

Stanley Druckenmiller's Portfolio Skips Megacap Tech Almost Entirely. Here's What He's Buying Instead.

Key Points Billionaire investor Stanley Druckenmiller has a long track record of success. His Duquesne Family office only holds one "Magnificent Seven" stock, and it cut way back on that one in Q1. Sandisk, Seagate, Broadcom, and Micron... Full story

Yahoo Finance • 2 months ago

US Stock Market Today S&P 500 Futures Edge Higher On Mixed Growth Signals

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. The Morning Bull - US Market Morning Update Friday, Aug, 7 2026 US stock futures are slightly higher this morning, with E... Full story

Yahoo Finance • 2 months ago

Here’s Why Baron Health Care Fund Remains Bullish on Insmed (INSM)

Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Health Care Fund". A copy of the letter is available to download here. The Fund gained 11.99% during the quarter, compared with the 10.48%... Full story

Yahoo Finance • 2 months ago

Insmed Incorporated’s (INSM) Commercial Acceleration Overshadows Q1 Stumble

Carillon Tower Advisers, an investment management company, released its second-quarter 2026 investor letter for the "Carillon Eagle Mid Cap Growth Fund". A copy of the letter is available to download here. Mid-cap stocks delivered strong r... Full story

Yahoo Finance • 2 months ago

XLV vs FHLC: Which Healthcare ETF Fits Your Portfolio?

Key Points The State Street Health Care Select Sector SPDR ETF manages $41.7 billion in assets under management (AUM), providing significantly higher liquidity than the Fidelity MSCI Health Care Index ETF Fidelity MSCI Health Care Index E... Full story

Yahoo Finance • 2 months ago

Concerns Over the Pace of its Brinsupri’s Launch Hurt Insmed (INSM)

ClearBridge Investments, a global equity manager, recently published second-quarter 2026 commentary for its "Small Cap Growth Strategy". A copy of the letter can be downloaded here. The Russell 2000 Growth Index increased by 25.6% in the s... Full story

Yahoo Finance • 2 months ago

Investors’ Concerns Hurt Insmed Incorporated (INSM) Despite Better-Than-Expected Results

Fred Alger Management, an investment management company, released its "Alger Mid Cap Focus Fund" second-quarter 2026 investor letter. A copy of the letter can be downloaded here. US equities strongly rebounded in the second quarter, with t... Full story

Yahoo Finance • 2 months ago

What Happens to Stocks After Joining the Nasdaq-100 (History Has a Clear Answer)

Joining the Nasdaq-100 represents a big milestone, as it includes the biggest non-financial companies on the Nasdaq. The idea is, once a company joins, it may see its share price advance as managers of funds tracking this index buy shares... Full story

Yahoo Finance • 2 months ago

Weekly Buzz: NVS, MRK Win FDA Nod; LLY Snaps Up ATAI; MANE Shines On Hair Loss Data

(RTTNews) - This week, the healthcare sector saw multiple U.S FDA and European Commission approvals, strategic licensing and M&A activity, as well as pivotal clinical trial readouts and regulatory setbacks. Positive data readouts spanned... Full story

Yahoo Finance • 2 months ago

These large-cap stocks head into Q2 earnings with Sell ratings

[stock market crash sell-off - trading screen in red] bunhill As second-quarter earnings season gets underway, investors may want to keep an eye on large-cap stocks carrying Sell or Strong Sell Quant Ratings, which reflect weaker scores a... Full story

Yahoo Finance • 3 months ago

Here’s Why TimesSquare Mid Cap Growth Strategy Added Insmed (INSM)

TimesSquare Capital Management, an equity investment management company, released its "U.S. Mid Cap Growth Strategy" first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Strategy fell 7.72% (net) in the quar... Full story

Yahoo Finance • 3 months ago

William Blair updates conviction list: Oracle in, Meta out and more

[Technology background image, graph, displaying analytical data about stock trading.] Donny DBM William Blair added Oracle (ORCL [https://seekingalpha.com/symbol/ORCL]), American Express (AXP [https://seekingalpha.com/symbol/AXP]), Ecolab... Full story

Yahoo Finance • 3 months ago

Mizuho Maintains an Outperform Rating on Insmed Incorporated (INSM)

Insmed Incorporated (NASDAQ:INSM) is among the Best Healthcare Stocks. On June 15, Mizuho lowered its price target on Insmed Incorporated (NASDAQ:INSM) to $192 from $202. It maintained an Outperform rating on the shares. The firm stated t... Full story

Yahoo Finance • 3 months ago

Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global Respiratory

BRIDGEWATER, N.J., June 23, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious d... Full story

Yahoo Finance • 3 months ago

Should Insmed’s (INSM) NASDAQ-100 Exit and TPIP Focus Require Action From Investors?

Insmed Incorporated was removed from the NASDAQ-100 Index on 19 June 2026, even as investor focus intensified on its experimental lung drug TPIP. Analyst commentary now emphasizes TPIP's upcoming clinical data as a potential turning point... Full story